• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Investigation into pathology of CAG repeat diseases and development of therapies

Research Project

Project/Area Number 14370204
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Neurology
Research InstitutionNagoya University

Principal Investigator

DOYU Manabu  Nagoya University, Graduate School of Medicine, Assistant Professor, 大学院・医学系研究科, 講師 (90293703)

Co-Investigator(Kenkyū-buntansha) SOBUE Gen  Nagoya University, Graduate School of Medicine, Professor, 大学院・医学系研究科, 教授 (20148315)
INUKAI Akira  Nagoya University, University Hospital, Research Associate, 医学部附属病院, 助手 (30314016)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥14,100,000 (Direct Cost: ¥14,100,000)
Fiscal Year 2003: ¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2002: ¥10,700,000 (Direct Cost: ¥10,700,000)
Keywordsspinal and bulbar muscular atrophy / androgen receptor / CAG repeat / transgenic mouse / castration / LHRH analogue / HSP70 / protein degradation / テストステロン / ホルモン治療 / Hsp
Research Abstract

Spinal and bulbar muscular atrophy (SBMA) is an inherited motor neuron disease. The molecular basis of SBMA is the expansion of a trinucleotide CAG repeat, which encodes the polyglutamine (polyQ) tract, in the androgen receptor (AR) gene. We generated transgenic mouse model expressing the full-length human AR containing either 24 or 97 CAG repeats under the control of a cytomegalovirus enhancer and a chicken β-actin promoter (AR-97Q mice). First, we castrated male AR-97Q mice. Castrated males showed profound improvement of their motor function, body weight, lifespan and nuclear accumulation of the mutant AR. On the other hand, testosterone administration caused a significant aggravation of their symptoms and enhanced nuclear accumulation of the mutant AR in female mice. Nuclear accumulation of the mutant protein with an expended polyQ tract is likely to be important in inducing neuronal cell dysfunction and degeneration in the majority of the polyQ diseases. Castration of the males pre … More vented the nuclear accumulation of the mutant AR by reducing the testosterone level, and improved their motor function. Similarly, testosterone blockade therapy, using leuprorelin, a LHRH analogue which reduces testosterone release from the testis, showed a marked amelioration of motor function and nuclear accumulation of the mutant AR. On the basis of these results, we started the double-blind clinical trial using leuprorelin.
Next, we cross-bred AR-97Q mice with mice over-expressing the inducible form of human HSP70. High expression of HSP70 markedly ameliorated motor function of AR-97Q mice. In double transgenic mice, nuclear mutant AR accumulation, particularly that of the large complex form, was significantly reduced. Monomeric mutant AR was also reduced in amount by HSP70 over-expression, suggesting the enhanced degradation of mutant AR. These findings suggest that HSP70 over-expression ameliorates SBMA phenotypes in mice by reducing nuclear-localized mutant AR, which probably due to enhanced mutant AR degradation. Less

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (23 results)

All Other

All Publications (23 results)

  • [Publications] Hiroaki Adachi: "HSP7O chaperone over-expression ameliorates phenotypes of the SBMA transgenic mouse model by reducing nuclear-localized mutant AR protein."The Journal of Neuroscience. 23. 2203-2211 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Masahisa Katsuno: "Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy."Nature Medicine. 9. 768-773 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nozomi Hishikawa: "Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Le bodies, multiple system atrophy, and amyotrophic lateral sclerosis."The American Journal Pathology. 163. 609-619 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takashi Ito: "Dorfin localizes to Lewy bodies and ubiquitylates synphilin-1."The Journal of Biological Chemistry. 278. 29106-29114 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Masahisa Katsuno: "Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy."Neuron. 35. 843-854 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Chen Sang: "c-Jun N-terminal kinase pathway mediates Lactacystin-induced cell death in a neuronal differentiated Neuro2a cell line."Brain Research Molecular Brain Research. 108. 7-17 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Adachi H, Katsuno M, Minamiyama M, Sang C, Pagoulatos G, Kusakabe M, Yoshiki A, Kobayashi Y, Doyu M, Sobue G.: "HSP7O chaperone over-expression ameliorates phenotypes of the SBMA transgenic mouse model by reducing nuclear-localized mutant AR protein."J Neurosci. 23. 2203-2211 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Katsuno M, Adachi H, Doyu M, Minamiyama M, Sang C, Kobayashi Y, Inukai A, Sobue G.: "Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy."Nat Med. 9. 768-773 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hishikawa N, Niwa J, Doyu M, Ito T, Ishigaki S, Hashizume Y, Sobue G.: "Dorfin localizes to the ubiquitylated inclusions in Padkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis."Am J Pathol. 163. 609-619 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ito T, Niwa J, Hishikawa N, Ishigaki S, Doyu M, Sobue G.: "Dorfin localizes to Lewy bodies and ubiquitylates synphilin-1."J Biol Chem. 278. 29106-29114 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Katsuno M, Adachi H, Kume A, Li M, Nakagomi Y, Niwa H, Sang C, Kobayashi Y, Doyu M, Sobue G.: "Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy."Neuron. 35. 843-854 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Sang C, Kobayashi Y, Du J, Katsumo M, Adachi H, Doyu M, Sobue G.: "c-Jun N-terminal kinase pathway mediates Lactacystin-induced cell death in a neuronal differentiated Neuro2a cell line."Brain Res Mol Brain Res. 108. 7-17 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hiroaki Adachi: "HSP70 chaperone over-expression ameliorates phenotypes of the SBMA transgenic mouse model by reducing nuclear-localized mutant AR protein."The Journal of Neuroscience. 23. 2203-2211 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Masahisa Katsuno: "Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy."Nature Medicine. 9. 768-773 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Nozomi Hishikawa: "Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lebodies, multiple system atrophy, and amyotrophic lateral sclerosis."The American Journal Pathology. 163. 609-619 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Takashi Ito: "Dorfin localizes to Lewy bodies and ubiquitylates synphilin-1."The Journal of Biological Chemistry. 278. 29106-29114 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Masahisa Katsuno: "Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy"Neuron. 35. 843-854 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Hiroaki Adachi: "HSP70 chaperone over-expression ameliorates phenotypes of the SBMA transgenic mouse model by reducing nuclear-localized mutantAR protein"J Neurosci. (in press). (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Masahisa Katsuno: "Transgenic mouse models of spinal and bulbar muscular atrophy"Cytogenet Genome Res. (in press). (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Chen Sang: "c-Jun N-terminal kinase pathway mediates Lactacystin-induced cell death in a neuronal differentiated Neuro2a cell line"Mol Brain Res. (in press). (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] 勝野 雅央: "球脊髄性筋萎縮症の動物モデル"神経進歩. 46. 726-735 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 祖父江 元: "運動ニューロン疾患、内科学 第8版"朝倉書店. 2344 (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Gen Sobue: "Spinal and bulbar muscular atrophy (SBMA). In Neurodegeneration. The Molecular Pathology of Dementia and Movement Disorders, Dickson D and Olsson Y (eds)"INS Neuropath Press : USA(in press). (2003)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi